Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2003 1
2007 1
2009 2
2010 2
2011 1
2012 3
2013 3
2014 6
2015 3
2016 5
2017 2
2018 1
2019 5
2020 9
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

51 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean pilar roles (229 results)?
The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models.
Gómez-Miragaya J, Morán S, Calleja-Cervantes ME, Collado-Sole A, Paré L, Gómez A, Serra V, Dobrolecki LE, Lewis MT, Diaz-Lagares A, Eroles P, Prat A, Esteller M, González-Suárez E. Gómez-Miragaya J, et al. Among authors: eroles p. Mol Cancer Res. 2019 Oct;17(10):2063-2076. doi: 10.1158/1541-7786.MCR-19-0040. Epub 2019 Jul 18. Mol Cancer Res. 2019. PMID: 31320385 Free article.
MicroRNAs in Breast Cancer: One More Turn in Regulation.
Eroles P, Tormo E, Pineda B, Espin E, Lluch A. Eroles P, et al. Curr Drug Targets. 2016;17(9):1083-100. doi: 10.2174/1389450116666150213114103. Curr Drug Targets. 2016. PMID: 25694121 Review.
Emerging EGFR antagonists for breast cancer.
Lluch A, Eroles P, Perez-Fidalgo JA. Lluch A, et al. Among authors: eroles p. Expert Opin Emerg Drugs. 2014 Jun;19(2):165-81. doi: 10.1517/14728214.2014.903919. Epub 2014 May 15. Expert Opin Emerg Drugs. 2014. PMID: 24831079 Review.
MicroRNA-33b Suppresses Epithelial-Mesenchymal Transition Repressing the MYC-EZH2 Pathway in HER2+ Breast Carcinoma.
Pattanayak B, Garrido-Cano I, Adam-Artigues A, Tormo E, Pineda B, Cabello P, Alonso E, Bermejo B, Hernando C, Martínez MT, Rovira A, Albanell J, Rojo F, Burgués O, Cejalvo JM, Lluch A, Eroles P. Pattanayak B, et al. Among authors: eroles p. Front Oncol. 2020 Sep 10;10:1661. doi: 10.3389/fonc.2020.01661. eCollection 2020. Front Oncol. 2020. PMID: 33014831 Free PMC article.
HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women.
Oltra SS, Cejalvo JM, Tormo E, Albanell M, Ferrer A, Nacher M, Bermejo B, Hernando C, Chirivella I, Alonso E, Burgués O, Peña-Chilet M, Eroles P, Lluch A, Ribas G, Martinez MT. Oltra SS, et al. Among authors: eroles p. Cancers (Basel). 2020 Feb 10;12(2):412. doi: 10.3390/cancers12020412. Cancers (Basel). 2020. PMID: 32050699 Free PMC article.
Autocrine CCL5 Effect Mediates Trastuzumab Resistance by ERK Pathway Activation in HER2-Positive Breast Cancer.
Zazo S, González-Alonso P, Martín-Aparicio E, Chamizo C, Luque M, Sanz-Álvarez M, Mínguez P, Gómez-López G, Cristóbal I, Caramés C, García-Foncillas J, Eroles P, Lluch A, Arpí O, Rovira A, Albanell J, Madoz-Gúrpide J, Rojo F. Zazo S, et al. Among authors: eroles p. Mol Cancer Ther. 2020 Aug;19(8):1696-1707. doi: 10.1158/1535-7163.MCT-19-1172. Epub 2020 May 13. Mol Cancer Ther. 2020. PMID: 32404410
Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
Garrido-Cano I, Constâncio V, Adam-Artigues A, Lameirinhas A, Simón S, Ortega B, Martínez MT, Hernando C, Bermejo B, Lluch A, Lopes P, Henrique R, Jerónimo C, Cejalvo JM, Eroles P. Garrido-Cano I, et al. Among authors: eroles p. Int J Mol Sci. 2020 Oct 8;21(19):7427. doi: 10.3390/ijms21197427. Int J Mol Sci. 2020. PMID: 33050096 Free PMC article.
The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer.
González-Alonso P, Zazo S, Martín-Aparicio E, Luque M, Chamizo C, Sanz-Álvarez M, Minguez P, Gómez-López G, Cristóbal I, Caramés C, García-Foncillas J, Eroles P, Lluch A, Arpí O, Rovira A, Albanell J, Piersma SR, Jimenez CR, Madoz-Gúrpide J, Rojo F. González-Alonso P, et al. Among authors: eroles p. Cancers (Basel). 2020 Apr 29;12(5):1108. doi: 10.3390/cancers12051108. Cancers (Basel). 2020. PMID: 32365528 Free PMC article.
51 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page